Learn More
Medchemexpress LLC Iacs-13909 | 2160546-07-4 | 99.9% | 377.27 | 100 MG

Supplier: Medchemexpress LLC HY137092100MG
IACS-13909 is a selective, potent, and orally active allosteric SHP2 inhibitor with an IC50 of 15.7 nM and a Kd of 32 nM. It demonstrates greater selectivity for SHP2 over other phosphatases, including SHP1. It exhibits antitumor activities and can suppress MAPK pathway signaling in receptor tyrosine kinase (RTK)-dependent cancers.
- Potently suppresses proliferation of wild-type SHP2 and KYSE-520 cells.
- Suppresses pERK and pMEK levels in wild-type SHP2 and KYSE-520 cells.
- Suppresses proliferation of both parental and NCI-H1975 CS cells in a dose-dependent manner.
- Potently suppresses tumor growth in NSG mice injected with KYSE-520 cells, achieving 100% tumor growth inhibition.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.